Skip to main content
SpringerLink
Log in

Non-steroidal anti-inflammatory drugs

  • Chapter
Principles of Immunopharmacology

  • 1388 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Selected readings

  • Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 231: 232–235

    CAS  Google Scholar 

  • Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88: 2692–2696

    Article  CAS  ADS  PubMed  Google Scholar 

  • Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenso WF et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. J Am Med Assoc 284: 1247–1255

    Article  CAS  Google Scholar 

  • Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC et al; VIGOR Study Group (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Eng J Med 343: 1520–1528

    Article  CAS  Google Scholar 

  • Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99: 13926–13931

    Article  CAS  ADS  PubMed  Google Scholar 

References

  1. Vane JR, Botting RM (1996) The history of anti-inflammatory drugs and their mode of action. In: N Bazan, J Botting, J Vane (eds): New Targets in Inflammation Inhibitors of COX-2 or Adhesion Molecules. Kluwer Academic Publishers and William Harvey Press, London: 1–12

    Google Scholar 

  2. Dreser H (1899) Pharmacologisches über Aspirin (Acetylsalicylsäure). Pflügers Arch 76: 306–318

    Article  CAS  Google Scholar 

  3. Douthwaite A, Lintott CA (1938) Gastroscopic observations of the effect of aspirin and certain other substances on the stomach. Lancet 2: 1222

    Article  Google Scholar 

  4. Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for the aspirin-like drugs. Nature 231: 232–235

    CAS  Google Scholar 

  5. Vane JR, Botting RM (1992) The Prostaglandins. In: JR Vane, RM Botting (eds): Aspirin and other Salicylates. Chapman & Hall, London, 17–34

    Google Scholar 

  6. Warner TD, Guiliano F, Vojnovic I, Bukasa A, Mitchell JA, Vane JR (1999) Nonsteroid drug selectivities for cyclooxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis. Proc Natl Acad Sci USA: 96: 7563–7568

    Article  CAS  ADS  PubMed  Google Scholar 

  7. Carr DP, Henn R, Green JR, Böttcher I (1986) Comparison of the systemic inhibition of thromboxane synthesis, anti-inflammatory activity and gastro-intestinal toxicity of non-steroidal anti-inflammatory drugs in the rat. Agents and Actions 19: 374–375

    Article  CAS  PubMed  Google Scholar 

  8. Flower RJ, Vane JR (1972) Inhibition of prostaglandin synthetase in brain explains the antipyretic activity of paracetamol (4-acetamidophenol). Nature 240: 410–411

    Article  CAS  PubMed  Google Scholar 

  9. Morrison AR, Moritz H, Needleman P (1978) Mechanism of enhanced renal biosynthesis of prostaglandins in ureter obstruction. Role of de novo protein biosynthesis. J Biol Chem 253: 8210–8212

    CAS  PubMed  Google Scholar 

  10. Kawakami M, Ishibashi S, Ogawa H, Murase T, Takaku F, Shibata S (1986) Cachectin/TNF as well as interleukin-1 induces prostacyclin synthesis in cultured vascular cells. Biochem Biophys Res Commun 141: 482–487

    Article  CAS  PubMed  Google Scholar 

  11. Honda A, Raz A, Needleman P (1990) Induction of cyclo-oxygenase synthesis in human promyelocytic leukemia (HL-60) cells during monocytic or granulocytic differentiation. Biochem J 272: 259–262

    CAS  PubMed  Google Scholar 

  12. Fu J-Y, Masferrer JL, Seibert K, Needleman P (1990) The induction and suppression of prostaglandin H2 synthase (cyclooxygenase) in human monocytes. J Biol Chem 265: 16737–16740

    CAS  PubMed  Google Scholar 

  13. Masferrer JL, Zweifel BS, Seibert K, Needleman P (1990) Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 86: 1375–1379

    Article  CAS  PubMed  Google Scholar 

  14. Masferrer JL, Zweifel BS, Seibert K, Needleman P (1990) Selective regulation of cellular cyclooxygenase by dexamethasone and endotoxin in mice. J Clin Invest 86: 1375–1379

    Article  CAS  PubMed  Google Scholar 

  15. Simmons DL, Levy DB, Yannoni Y, Erikson RL (1989) Identification of a phorbol ester-repressible v-srcinducible gene. Proc Natl Acad Sci USA 86: 1178–1182

    Article  CAS  ADS  PubMed  Google Scholar 

  16. Xie W, Chipman JG, Robertson DL, Erikson RL, Simmons DL (1991) Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc Natl Acad Sci USA 88: 2692–2696

    Article  CAS  ADS  PubMed  Google Scholar 

  17. Kujubu DA, Fletcher BS, Varnum BC, Lim RW, Herschman HR (1991) TIS10, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells, encodes a novel prostaglandin synthase/cyclooxygenase homologue. J Biol Chem 266: 12866–12872

    CAS  PubMed  Google Scholar 

  18. Simmonds DL, Xie W, Chipman J, Evett G (1991) Multiple cyclooxygenases: cloning of a mitogen-inducible form. In: M Bailey (ed): Prostaglandins, Leukotrienes, Lipoxins and PAF. Plenum Press, London, 67–68

    Google Scholar 

  19. McAdam BF, Catella-Lawson F, Mardini IA, Kapoor S, Fitzgerald GA (1999) Systemic biosynthesis of prostacyclin by cyclooxygenase (COX-2): The human pharmacology of a selective inhibitor of COX-2. Proc Natl Acad Sci USA: 96: 272–277

    Article  CAS  ADS  PubMed  Google Scholar 

  20. Willoughby DA, Tomlinson A, Gilroy D, Willis D (1996) Inducible enzymes with special reference to the inflammatory response. In: JR Vane, JH Botting, RM Botting (eds): Improved Non-steroid Anti-inflammatory Drugs. COX-2 Enzyme Inhibitors. Kluwer and William Harvey Press, London, 67–83

    Google Scholar 

  21. Sano H, Hla T, Maier JA, Crofford LJ, Case JP, Maciag T, Wilder RL (1992) In vivo cylooxygenase expression in synovial tissues of patients wth rheumatoid arthritis and osteoarthritis and rats with adjuvant and streptococcal cell wall arthritis. J Clin Invest 89: 97–108

    Article  CAS  PubMed  Google Scholar 

  22. Patrignani P, Panara MR, Greco A, Fusco O, Natoli C, Iacobelli S, Cipollone F, Ganci A, Creminon C, Maclouf J et al (1994) Biochemical and pharmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoperoxide synthases. J Pharmacol Exp Ther 271: 1705–1710

    CAS  PubMed  Google Scholar 

  23. Picot D, Loll PJ, Garavito RM (1994) The x-ray crystal structure of the membrane protein prostaglandin H2 synthase-1. Nature 367: 243–249

    Article  CAS  ADS  PubMed  Google Scholar 

  24. Luong C, Miller A, Barnett J, Chow J, Ramesha C, Browner MF (1996) Flexibility of the NSAID binding site in the structure of human cyclooxygenase-2. Nat Struct Biol 3: 927–933

    Article  CAS  PubMed  Google Scholar 

  25. Wong E, Bayly C, Waterman HL, Reindeau D, Mancini JA (1997) Conversion of prostaglandin G/H synthase-1 into an enzyme sensitive to PGHS-2-selective inhibitors by a double His513 to Arg and Ile523 to Val mutation. J Biol Chem 272: 9280–9286

    Article  CAS  PubMed  Google Scholar 

  26. Browner MF (1998) The structure of human COX-2 and selective inhibitors. In: J Vane, J Botting J (eds): Selective COX-2 Inhibitors. Pharmacology, Clinical Effects and Therapeutic Potential. Kluwer and William Harvey Press, London, 19–26

    Google Scholar 

  27. Silverstein FE, Faich G, Goldstein JL, Simon LS, Pincus T, Whelton A, Makuch R, Eisen G, Agrawal NM, Stenson WF et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomised controlled trial. Celecoxib Long-term Arthritis Safety Study. J Am Med Assoc 284: 1247–1255

    Article  CAS  Google Scholar 

  28. Bombardier C, Laine L, Reicin A, Shapiro D, Burgos-Vargas R, Davis B, Day R, Ferraz MB, Hawkey CJ, Hochberg MC et al; VIGOR Study Group (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. N Engl J Med 343: 1520–1528

    Article  CAS  PubMed  Google Scholar 

  29. Giovannucci E, Egan KM, Hunter DJ (1995) Aspirin and the risk of colorectal cancer. N Engl J Med 333: 609–614

    Article  CAS  PubMed  Google Scholar 

  30. Greenberg ER, Baron JA, Freeman DH, Mandel JS, Haile R (1993) Reduced risk of large bowel adenomas among aspirin users. The Polyp Prevention Study Group. J Natl Cancer Inst 85: 912–916

    Article  CAS  PubMed  Google Scholar 

  31. Thun MJ, Namboodiri MM, Heath CWJ (1991) Aspirin use and reduced risk of coloc cancer. N Engl J Med 325: 1593–1596

    Article  CAS  PubMed  Google Scholar 

  32. Thun MJ, Namboodiri MM, Calle EE, Flandes WD, Heath CW (1993) Aspirin use and risk of fatal cancer. Cancer Res 53: 1322–1327

    CAS  PubMed  Google Scholar 

  33. Peleg II, Maibach HT, Brown SH, Wilcox CM (1994) Aspirin and nonsteroidal antiinflammatory drug use and the risk of subsequent colorectal cancer. Arch Int Med 154: 394–399

    Article  CAS  Google Scholar 

  34. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Aspirin use and the risk of colorectal cancer and adenoma in male health professionals. Ann Intern Med 121: 241–246

    CAS  PubMed  Google Scholar 

  35. Eberhart CE, Coffey RJ, Radhika A (1994) Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology 107:1183–1188

    CAS  PubMed  Google Scholar 

  36. Giardello FM, Hamilton SR, Krush AJ (1993) Treatment of colonic and rectal carcinomas with sulindac in familial adenomatous polyposis. N Engl J Med 328: 1313–1316

    Article  Google Scholar 

  37. Waddell WR, Loughry RW (1983) Sulindac for polyposis of the colon. J Surg Oncol 24: 83–87

    Article  CAS  PubMed  Google Scholar 

  38. Waddell WR, Gasner GF, Cerise EJ, Loughry RW (1989) Sulindac for polyposis of the colon. Am J Surg 157:175–178

    Article  CAS  PubMed  Google Scholar 

  39. Reddy BS, Rao CV, Rivenson A, Kellof G (1993) Inhibitor effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis 14: 1493–1497

    Article  CAS  PubMed  Google Scholar 

  40. Steinbach G, Lynch PM, Phillips RK, Wallace MH, Hawk E, Gordon GB (2000) The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med 342: 1946–1952

    Article  CAS  PubMed  Google Scholar 

  41. Ristimaki A, Narko K, Nieminen, Saukkonen K (2001) Role of cyclooxygenase-2 in carcinogenesis other than colorectal cancer. In: JR Vane, RM Botting (eds): Therapeutic Roles of Selective COX-2 Inhibitors. William Harvey Press, London, 418–441

    Google Scholar 

  42. Bennett PR, Elder MG (1992) The mechanisms of preterm labour: common genital tract pathogens do not metabolise arachidonic acid to prostaglandins or other eicosanoids. Am J Obstet Gynecol 166: 1541–1545

    CAS  PubMed  Google Scholar 

  43. Sawdy R, Slater D, Fisk N, Edmonds DK, Bennett P (1997) Use of a cyclo-oxygenase type-2-selective nonsteroidal anti-inflammatory agent to prevent preterm delivery. Lancet 350: 265–266

    Article  CAS  PubMed  Google Scholar 

  44. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R (1999) Neonatal end-stage renal failure associated with maternal ingestion of cyclo-oxygenase-type-1 selective inhibitor nimesulide as tocolytic. Lancet 354: 1615

    Article  CAS  PubMed  Google Scholar 

  45. Allport V, Bennett P (2001) Cyclooxygenase enzymes and human labour. In: JR Vane, RM Botting (eds): Therapeutic Roles of Selective COX-2 Inhibitors. William Harvey Press, London, 252–273

    Google Scholar 

  46. Stewart WF, Kawas C, Corrada M, Metter EJ (1997) Risk of Alzheimer’s disease and duration of NSAID use. Neurology 48: 626–632

    CAS  PubMed  Google Scholar 

  47. Pasinetti GM, Aisen PS (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer’s disease brain. Neuroscience 87: 319–324

    Article  CAS  PubMed  Google Scholar 

  48. Lim GP, Yang F, Chu T, Chen P, Beech W, Teter B, Tran T, Ubeda O, Ashe KH, Frautschy SA et al (2000) Ibuprofen suppresses plaque pathology and inflammation in a mouse model for Alzheimer’s disease. J Neurosci 20: 5709–5714

    CAS  PubMed  Google Scholar 

  49. McGeer PL (2000) Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer’s disease. Drugs Aging 17: 1–11

    Article  CAS  PubMed  Google Scholar 

  50. Sainati SM, Ingram DM, Talwalker S, Geis GS (2000) Results of a double-blind, randomized, placebo-controlled study of celecoxib in the treatment of progression of Alzheimer’s disease. Abstracts of the Sixth International Stockholm/Springgfield Symposium on Advances in Alzheimer Therapy. April 5–8, 2000

    Google Scholar 

  51. Weggen S, Eriksen JL, Das P, Sagi SA, Wang R, Pietrzik CU, Findlay KA, Smith TE, Murphy MP, Bulter T et al (2001) A subset of NSAIDs lower amyloidogenic Aß42 independently of cyclooxygenase activity. Nature 414: 212–216

    Article  CAS  ADS  PubMed  Google Scholar 

  52. Zandi PP, Anthony JC, Hayden KM, Mehta K, Mayer L, Breitner JC (2002) Reduced incidence of AD with NSAID but not H2 receptor antagonists. The Cache County study. Neurology 59: 880–886

    CAS  PubMed  Google Scholar 

  53. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL (2002) COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99: 13926–13931

    Article  CAS  ADS  PubMed  Google Scholar 

  54. Simmons DL, Botting RM, Robertson PM, Madsen ML, Vane JR (1999) Induction of an acetaminophen-sensitive cyclooxygenase with reduced sensitivity to nonsteroid antiinflammatory drugs. Proc Natl Acad Sci USA 96: 3275–3280

    Article  CAS  ADS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Nephrology and Experimental Medicine, The John Vane Science Centre, St. Bartholomew’s and the Royal London School of Medicine and Dentistry, Charterhouse Square, London, EC1M 6BQ, UK

    Regina M. Botting & Jack H. Botting

Authors
  1. Regina M. Botting
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jack H. Botting
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Faculty of Pharmacy, Department of Pharmacology and Pathophysiology, Sorbonnelaan 16, 3584 CA, Utrecht, The Netherlands

    Frans P. Nijkamp

  2. PLIVA Research Institute Ltd., Prilaz baruna Filipovića 29, HR-10 000, Zagreb, Croatia

    Michael J. Parnham

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Birkhäuser Verlag

About this chapter

Cite this chapter

Botting, R.M., Botting, J.H. (2005). Non-steroidal anti-inflammatory drugs. In: Nijkamp, F.P., Parnham, M.J. (eds) Principles of Immunopharmacology. Birkhäuser Basel. https://doi.org/10.1007/3-7643-7408-X_27

Download citation

Publish with us

Policies and ethics

Search

Navigation